-
Product Insights
![]()
Inflammatory Disease Markers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Inflammatory Disease Markers Pipeline Market Report Overview Inflammatory Disease Markers are antigens/antibodies that detect specific antigens/antibodies produced by bone, cartilage, or any other inflammatory disease activity. The Inflammatory Disease Markers pipeline market research report provides comprehensive information about the inflammatory disease markers pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress. Key Segments ·       Anti-Cyclic Citrullinated Peptide Antibody (Anti-CCP) Analyzer Tests ·       C-Reactive Protein (CRP)...
-
Company Profile
![]()
LumiraDx Ltd – Company Profile
LumiraDx Ltd (LumiraDx) is a company that provides point-of-care (PoC) diagnostic tests and solutions. The company is focused on transforming community-based healthcare by giving essential diagnostic information to healthcare practitioners at the time of need, enabling better informed medical decisions to enhance health outcomes while decreasing costs. Its product portfolio includes severe acute respiratory syndrome (SARS) coronavirus 2 (CoV-2) antigen test, SARS-CoV-2 antibody test, INR test, and D-Dimmer test. It offers solutions such as to engage, a patient program, INRstar,...
Add to Basket -
Product Insights
![]()
Respiratory Disease Tests – LumiraDx – LUMIRADX
GlobalData, the industry analysis specialist, has released its latest report: Respiratory Disease Tests - LumiraDx - LUMIRADX. The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. In addition, the final selling pricing of medical devices is also impacted by the discounting...
-
Product Insights
![]()
COVID-19 Tests – LumiraDx – LUMIRADX
GlobalData, the industry analysis specialist, has released its latest report: COVID-19 Tests - LumiraDx - LUMIRADX. The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. In addition, the final selling pricing of medical devices is also impacted by the discounting policy...
-
Product Insights
![]()
LumiraDx Ltd Pipeline Insight and Competitive Landscape, 2023
LumiraDx Ltd (LumiraDx), is a provider of point of care (PoC) diagnostic tests and solutions. The company is focused on transforming community-based healthcare by giving essential diagnostic information to healthcare practitioners at the time of need, enabling better informed medical decisions to enhance health outcomes while decreasing costs. Its product portfolio includes severe acute respiratory syndrome (SARS) coronavirus 2 (CoV-2) antigen test, SARS-CoV-2 antibody test, INR test, and D-Dimmer test. It offers solutions such as to engage, a patient program;...
-
Product Insights
![]()
Clinical Chemistry Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
The clinical chemistry segment comprises reagents, test kits, and electrodes. This aid in determining the concentration or activity of biomolecules, such as proteins, carbohydrates, lipids, enzymes, minerals, or other small molecules. These biomolecules could be easily collected via body fluids such as blood, serum or plasma, and urine. The clinical chemistry pipeline market research report provides comprehensive information about the clinical chemistry pipeline products with a comparative analysis of the products at various stages of development and information about the...
-
Track & Monitor
![]()
Artificial Intelligence in Medical Devices: Treatment Evaluation Models
Innovations in medical devices industry is relentless, making it hard to stay-on top of the dynamically evolving industry landscape and in early identification of profound shifts posing high risk of being disrupted if detected too late. GlobalData's coherent data-driven approach, using multiple forward-looking alternative datasets, empowers clients by decoding in advance the disruptive innovations in medical devices industry. Using patent data, GlobalData's proprietary industry innovation s-curve identifies specific innovation areas and their stage of evolution, i.e., whether they are emerging,...
-
Product Insights
![]()
Immunochemistry Rapid Tests and POC Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Spot test kits intended generally for rapid diagnosis, with immediate results, through immuno assays. Some of the tests carried out using immunochemistry rapid test include rabies virus test, allergenic food proteins, and enteric infection. The immunochemistry rapid tests and POC pipeline market research report provides comprehensive information about the immunochemistry rapid tests and POC pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
-
Product Insights
![]()
Mycobacterium Tuberculosis Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Traditional diagnosis of Mycobacterial infections depends upon smear positivity in sputum samples, culture, and chest radiography. For rapid diagnosis, polymerase chain reaction (PCR), immune-based assays such as enzyme-linked immunosorbent assay (ELISA), skin patch test, and rapid culture systems are performed. The Mycobacterium tuberculosis tests pipeline market research report provides comprehensive information about the Mycobacterium tuberculosis tests pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
-
Product Insights
![]()
Bacteriology Rapid Tests and POC Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Bacteriology Rapid Tests & POC comprises rapid test kits intended for rapid diagnosis, with immediate results, through immuno assays for Chlamydia, H. pylori, Streptococci, and Syphilis. The Bacteriology Rapid Tests & POC pipeline market research report provides comprehensive information about the Bacteriology Rapid Tests & POC pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.